NDAINHALATIONGAS
Approved
Mar 1976
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
2/8 — Basic
XENON XE 133 (xenon xe-133) by Lantheus Medical Imaging is radiopharmaceutical activity [moa]. First approved in 1976.
Drug data last refreshed 6h ago · AI intelligence enriched 1w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
Xenon XE-133 is a radioactive noble gas radiopharmaceutical administered via inhalation for diagnostic imaging of pulmonary ventilation and cerebral blood flow. It works through radiopharmaceutical activity, emitting gamma radiation that is detected by imaging equipment to assess lung function and brain perfusion. Patients inhale the gas as part of nuclear medicine diagnostic procedures.
LOE Approaching
Product is in late-stage lifecycle with moderate competitive pressure (30%), indicating a mature, stable franchise with limited growth opportunities and potential team consolidation.
Mechanism of Action
Radiopharmaceutical Activity
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on Xenon XE-133 offers limited career growth given its mature, LOE-approaching lifecycle and zero linked job postings. This role suits professionals seeking stability in diagnostic imaging or those transitioning toward regulatory and compliance functions rather than commercial expansion.
Medical Affairs SpecialistRegulatory Affairs Specialist
Worked on XENON XE 133 at Lantheus Medical Imaging? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.